I am a physician with good insurance, but every year we have faced higher out-of-pocket cost for my son’s EpiPen.

Consumer Reports has no financial relationship with advertisers on this site. Consumer Reports has no financial relationship with advertisers on this site. As parents scramble to find auto-injectors ...

The U.S. Food and Drug Administration has approved ARS Pharmaceuticals’ nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions. The spray, which will be sold ...

Add Yahoo as a preferred source to see more of our stories on Google. The makers of EpiPens agreed to pay $264 million to settle a class action lawsuit alleging that they had created a scheme to ...

A widespread shortage of EpiPens already has parents scrambling. Now with children returning to school without possible medication that could prevent them from going into anaphylactic shock, parents ...

The emergency epinephrine market is about to be flush with options. At least three new epinephrine marketers are challenging Mylan’s EpiPen, the longtime market leader still reeling after a price-hike ...

Aquestive Therapeutics’ oral epinephrine film has cleared another hurdle on its path to a pivotal clinical trial, holding its own against the intramuscular injection incumbent in a study of healthy ...

The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market. Mylan acquired the rights to the injector pen for treating ...

You could almost hear the sigh of relief from patients when the FDA earlier this month approved Teva Pharmaceutical’s application to market the first generic ...

Mylan CEO Heather Bresch takes her seat on Capitol Hill in Washington, Wednesday, Sept. 21, 2016, prior to testifying before the House Oversight Committee hearing on EpiPen price increases. Bresch, ...

U.S. District Judge Daniel Crabtree in June tossed claims brought under the U.S. Racketeer Influenced and Corrupt Organizations Act and some of the antitrust allegations against Mylan Pharmaceuticals, ...